Y. Morimoto et al., Upregulation of the expression of Fas antigen and Fas ligand in a human submandibular gland ductal cell line by okadaic acid, ARCH ORAL B, 45(8), 2000, pp. 657-666
Fas receptor is a member of a superfamily of receptors characterized by cys
teine-rich motifs in the extracellular domain of the molecule. Binding of F
as ligand to the receptor leads to receptor activation and the induction of
intracellular signals that result in apoptotic cell death. In the present
study, the expression of mRNA and proteins of Fas receptor and Fas ligand w
ere examined in human submandibular gland ductal (HSG) cells treated with o
kadaic acid by reverse transcriptase-polymerase chain reaction (RT-PCR) and
immunoblot analysis. Six hundred and eighty-two bp of the PCR product of F
as receptor mRNA was detected in HSG cells and a protein with an estimated
molecular weight of 58,000 was expressed in HSG cells. Treatment of HSG cel
ls with an agonistic anti-Fas monoclonal antibody resulted in death of HSG
cells, indicating that the functional Fas receptor protein is expressed in
HSG cells. Fas receptor protein expression stimulated by okadaic acid was e
levated in a dose- and time-dependent manner, with maximal expression at 20
nM and 48 h treatment. Fas ligand mRNA was also detected constitutively in
HSG cells by RT-PCR. Okadaic acid stimulated the expression of Fas ligand
protein in HSG cells in a time-dependent manner, while the expression of th
e ligand was low in untreated HSG cells. The molecular weight of Fas ligand
was estimated as 68,000. An antagonistic anti-Fas ligand monoclonal antibo
dy prevented okadaic acid-induced death in HSG cells in a dose-dependent fa
shion as determined by WST-1 assay. The results indicate that the expressio
n of Fas receptor and ligand is regulated by protein phosphatase(s) sensiti
ve to okadaic acid and is involved in okadaic acid-induced apoptosis in HSG
cells, The results also suggest that the Fas receptor-ligand system might
regulate apoptosis in HSG cells. (C) 2000 Elsevier Science Ltd. All rights
reserved.